Establishment Labs Holdings logo

Establishment Labs HoldingsNASDAQ: ESTA

Profile

Sector:

Healthcare

Country:

Costa Rica

IPO:

19 July 2018

Next earnings report:

28 February 2025

Last dividends:

N/A

Next dividends:

N/A
$1.24 B
-39%vs. 3y high
76%vs. sector
-vs. 3y high
-vs. sector
-96%vs. 3y high
99%vs. sector
-46%vs. 3y high
74%vs. sector

Price

regular market | 6 min ago
$43.08+$0.58(+1.36%)

Dividend

No data over the past 3 years
$40.23 M$44.69 M
$40.23 M-$16.68 M

Analysts recommendations

Institutional Ownership

ESTA Latest News

Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
seekingalpha.com09 November 2024 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Conference Call Participants Allen Gong - JPMorgan Matt Taylor - Jefferies Sam Eiber - BTIG Anthony Pettinari - Citi Josh Jennings - TD Cowen Anthony Petrone - Mizuho Group Operator Good afternoon. Welcome to Establishment Labs Third Quarter 2024 Earnings Conference Call.

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates
zacks.com07 November 2024 Sentiment: NEUTRAL

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $1.12 per share a year ago.

Establishment Labs Announces $50 Million Registered Direct Offering
businesswire.com07 November 2024 Sentiment: POSITIVE

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of 765,696 common shares and pre-funded warrants to purchase up to 328,161 common shares in a registered direct offering for a.

Establishment Labs Receives U.S. FDA Approval for Motiva Implants
businesswire.com26 September 2024 Sentiment: POSITIVE

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in.

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
zacks.com06 August 2024 Sentiment: NEUTRAL

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
zacks.com25 June 2024 Sentiment: POSITIVE

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
Seeking Alpha28 February 2024 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript

Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research28 February 2024 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.55 per share a year ago.

Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research21 February 2024 Sentiment: NEGATIVE

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Establishment Labs Stock Is Crashing Today
The Motley Fool08 November 2023 Sentiment: NEGATIVE

Establishment Labs missed consensus revenue and earnings estimates in Q3. The company also slashed its full-year guidance.

What type of business is Establishment Labs Holdings?

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

What sector is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Healthcare sector

What industry is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Medical Devices industry

What country is Establishment Labs Holdings from?

Establishment Labs Holdings is headquartered in Costa Rica

When did Establishment Labs Holdings go public?

Establishment Labs Holdings initial public offering (IPO) was on 19 July 2018

What is Establishment Labs Holdings website?

https://www.establishmentlabs.com

Is Establishment Labs Holdings in the S&P 500?

No, Establishment Labs Holdings is not included in the S&P 500 index

Is Establishment Labs Holdings in the NASDAQ 100?

No, Establishment Labs Holdings is not included in the NASDAQ 100 index

Is Establishment Labs Holdings in the Dow Jones?

No, Establishment Labs Holdings is not included in the Dow Jones index

When was Establishment Labs Holdings the previous earnings report?

No data

When does Establishment Labs Holdings earnings report?

The next expected earnings date for Establishment Labs Holdings is 28 February 2025